UNITEDHEALTH GROUP INC acquired Catamaran Corporation for $61.50 per share in cash (approximately $12.8 billion), a transaction completed in July 2015, structured as all cash.
Catamaran Corporation operates in OptumRx, is based in Schaumburg, Illinois, USA. Catamaran (NASDAQ: CTRX; TSX: CCT) was a leading pharmacy benefit management (PBM) services and technology company. It was combined with UnitedHealth's free-standing pharmacy care services business, OptumRx.
Combining OptumRx's medical synchronization and information capabilities with Catamaran's technology leadership and flexible services to help manage growth in high-cost specialty pharmaceuticals; the combined business expected to fulfill more than one billion scripts.
Scale and technology to compete in the consolidating PBM market and manage specialty drug spend. Diversified OptumRx's customer and business mix; expected accretion of about $0.30 per share to UnitedHealth Group net earnings in 2016. OptumRx
Advisory firms were not disclosed for this transaction.